FOXC1 Is a Potential Prognostic Biomarker with Functional Significance in Basal-like Breast Cancer

被引:213
作者
Ray, Partha S. [2 ]
Wang, Jinhua [1 ]
Qu, Ying [1 ,5 ]
Sim, Myung-Shin [3 ]
Shamonki, Jaime [4 ]
Bagaria, Sanjay P. [2 ]
Ye, Xing [3 ]
Liu, Bingya [5 ]
Elashoff, David [6 ]
Hoon, Dave S. [1 ]
Walter, Michael A. [7 ]
Martens, John W. [8 ]
Richardson, Andrea L. [9 ]
Giuliano, Armando E. [2 ]
Cui, Xiaojiang [1 ]
机构
[1] John Wayne Canc Inst, Dept Mol Oncol, Santa Monica, CA 90404 USA
[2] John Wayne Canc Inst, Dept Surg Oncol, Santa Monica, CA 90404 USA
[3] John Wayne Canc Inst, Dept Biostat, Santa Monica, CA 90404 USA
[4] St Johns Hlth Ctr, Dept Pathol, Santa Monica, CA USA
[5] Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Surg, Shanghai 200030, Peoples R China
[6] Univ Calif Los Angeles, Sch Med, Div Gen Internal Med, Los Angeles, CA USA
[7] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada
[8] Erasmus MC, Dept Med Oncol, Rotterdam, Netherlands
[9] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA
关键词
EXPRESSION SIGNATURE; MOLECULAR PORTRAITS; TUMORS; IDENTIFICATION; CARCINOMA; SURVIVAL; SUBTYPES; PREDICTOR; PATTERNS; FEATURES;
D O I
10.1158/0008-5472.CAN-09-4120
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Gene expression signatures for a basal-like breast cancer (BLBC) subtype have been associated with poor clinical outcomes, but a molecular basis for this disease remains unclear. Here, we report overexpression of the transcription factor FOXC1 as a consistent feature of BLBC compared with other molecular subtypes of breast cancer. Elevated FOXC1 expression predicted poor overall survival in BLBC (P = 0.0001), independently of other clinicopathologic prognostic factors including lymph node status, along with a higher incidence of brain metastasis (P = 0.02) and a shorter brain metastasis-free survival in lymph node-negative patients (P < 0.0001). Ectopic overexpression of FOXC1 in breast cancer cells increased cell proliferation, migration, and invasion, whereas shRNA-mediated FOXC1 knockdown yielded opposite effects. Our findings identify FOXC1 as a theranostic biomarker that is specific for BLBC, offering not only a potential prognostic candidate but also a potential molecular therapeutic target in this breast cancer subtype. Cancer Res; 70(10); 3870-6. (C) 2010 AACR.
引用
收藏
页码:3870 / 3876
页数:7
相关论文
共 25 条
[1]   NEW LOOK AT STATISTICAL-MODEL IDENTIFICATION [J].
AKAIKE, H .
IEEE TRANSACTIONS ON AUTOMATIC CONTROL, 1974, AC19 (06) :716-723
[2]   Molecular Characterization of Breast Cancer with High-Resolution Oligonucleotide Comparative Genomic Hybridization Array [J].
Andre, Fabrice ;
Job, Bastien ;
Dessen, Philippe ;
Tordai, Attila ;
Michiels, Stefan ;
Liedtke, Cornelia ;
Richon, Catherine ;
Yan, Kai ;
Wang, Bailang ;
Vassal, Gilles ;
Delaloge, Suzette ;
Hortobagyi, Gabriel N. ;
Symmans, W. Fraser ;
Lazar, Vladimir ;
Pusztai, Lajos .
CLINICAL CANCER RESEARCH, 2009, 15 (02) :441-451
[3]  
ASLAKSON CJ, 1992, CANCER RES, V52, P1399
[4]   Regulation of FOXC1 stability and transcriptional activity by an epidermal growth factor-activated mitogen-activated protein kinase signaling cascade [J].
Berry, FB ;
Mirzayans, F ;
Walter, MA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (15) :10098-10104
[5]   Cell type-specific DNA methylation patterns in the human breast [J].
Bloushtain-Qimron, Noga ;
Yao, Jun ;
Snyder, Eric L. ;
Shipitsin, Michail ;
Campbell, Lauren L. ;
Mani, Sendurai A. ;
Hua, Min ;
Chen, Haiyan ;
Ustyansky, Vadim ;
Antosiewicz, Jessica E. ;
Argani, Pedram ;
Halushka, Marc K. ;
Thomson, James A. ;
Pharoah, Paul ;
Porgador, Angel ;
Sukumar, Saraswati ;
Parsons, Ramon ;
Richardson, Andrea L. ;
Stampfer, Martha R. ;
Gelman, Rebecca S. ;
Nikolskaya, Tatiana ;
Nikolsky, Yuri ;
Polyak, Kornelia .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (37) :14076-14081
[6]   Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study [J].
Carey, Lisa A. ;
Perou, Charles M. ;
Livasy, Chad A. ;
Dressler, Lynn G. ;
Cowan, David ;
Conway, Kathleen ;
Karaca, Gamze ;
Troester, Melissa A. ;
Tse, Chiu Kit ;
Edmiston, Sharon ;
Deming, Sandra L. ;
Geradts, Joseph ;
Cheang, Maggie C. U. ;
Nielsen, Torsten O. ;
Moorman, Patricia G. ;
Earp, H. Shelton ;
Millikan, Robert C. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (21) :2492-2502
[7]   Triple-negative breast cancer: Clinical features and patterns of recurrence [J].
Dent, Rebecca ;
Trudeau, Maureen ;
Pritchard, Kathleen I. ;
Hanna, Wedad M. ;
Kahn, Harriet K. ;
Sawka, Carol A. ;
Lickley, Lavina A. ;
Rawlinson, Ellen ;
Sun, Ping ;
Narod, Steven A. .
CLINICAL CANCER RESEARCH, 2007, 13 (15) :4429-4434
[8]   Caveolin 1 and caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype [J].
Elsheikh, S. E. ;
Green, A. R. ;
Rakha, E. A. ;
Samaka, R. M. ;
Ammar, A. A. ;
Powe, D. ;
Reis-Filho, J. S. ;
Ellis, I. O. .
BRITISH JOURNAL OF CANCER, 2008, 99 (02) :327-334
[9]   Identification of molecular apocrine breast tumours by microarray analysis [J].
Farmer, P ;
Bonnefoi, H ;
Becette, V ;
Tubiana-Hulin, M ;
Fumoleau, P ;
Larsimont, D ;
MacGrogan, G ;
Bergh, J ;
Cameron, D ;
Goldstein, D ;
Duss, S ;
Nicoulaz, AL ;
Brisken, C ;
Fiche, M ;
Delorenzi, M ;
Iggo, R .
ONCOGENE, 2005, 24 (29) :4660-4671
[10]   Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors [J].
Herschkowitz, Jason I. ;
Simin, Karl ;
Weigman, Victor J. ;
Mikaelian, Igor ;
Usary, Jerry ;
Hu, Zhiyuan ;
Rasmussen, Karen E. ;
Jones, Laundette P. ;
Assefnia, Shahin ;
Chandrasekharan, Subhashini ;
Backlund, Michael G. ;
Yin, Yuzhi ;
Khramtsov, Andrey I. ;
Bastein, Roy ;
Quackenbush, John ;
Glazer, Robert I. ;
Brown, Powel H. ;
Green, Jeffrey E. ;
Kopelovich, Levy ;
Furth, Priscilla A. ;
Palazzo, Juan P. ;
Olopade, Olufunmilayo I. ;
Bernard, Philip S. ;
Churchill, Gary A. ;
Van Dyke, Terry ;
Perou, Charles M. .
GENOME BIOLOGY, 2007, 8 (05)